MAPT and Alzheimer disease: The above biomarkers associated with immunity, inflammation, and metabolism as well as apoptosis, mitochondrial dysfunction, or oxidative stress are basically not specific to AD; however, they may be suitable for its diagnosis when combined with other core biomarkers, such as Aβ and tau, and be targets for the treatment of AD.